{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:45Z","timestamp":1777870365724,"version":"3.51.4"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40620-020-00808-y","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:02:52Z","timestamp":1595592172000},"page":"661-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of proton pump inhibitors in dialysis patients: a double-edged sword?"],"prefix":"10.1093","volume":"34","author":[{"given":"Geoffroy","family":"Desbuissons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Mercadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"issue":"3","key":"808_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00228-019-02810-1","volume":"76","author":"M Lassalle","year":"2020","unstructured":"Lassalle M, Le Tri T, Bardou M, Biour M, Kirchgesner J, Rouby F, Dumarcet N, Zureik M, Dray Spira R (2020) Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol 76(3):449\u2013457. https:\/\/doi.org\/10.1007\/s00228-019-02810-1","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"808_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","volume":"30","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MM, Yang HC, Wu CC, Li YC (2019) Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int 30(1):103\u2013114. https:\/\/doi.org\/10.1007\/s00198-018-4788-y","journal-title":"Osteoporos Int"},{"issue":"22","key":"808_CR3","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, Corley DA (2013) Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310(22):2435\u20132442. https:\/\/doi.org\/10.1001\/jama.2013.280490","journal-title":"JAMA"},{"issue":"7","key":"808_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","volume":"37","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S, Erickson SB (2015) Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail 37(7):1237\u20131241. https:\/\/doi.org\/10.3109\/0886022X.2015.1057800","journal-title":"Ren Fail"},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.08.035","volume":"277","author":"M Casula","year":"2018","unstructured":"Casula M, Scotti L, Galimberti F, Mozzanica F, Tragni E, Corrao G, Catapano AL (2018) Use of proton pump inhibitors and risk of ischemic events in the general population. Atherosclerosis 277:123\u2013129. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.035","journal-title":"Atherosclerosis"},{"issue":"3","key":"808_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.12698","volume":"283","author":"TSG Sehested","year":"2018","unstructured":"Sehested TSG, Gerds TA, Fosb\u00f8l EL, Hansen PW, Charlot MG, Carlson N, Hlatky MA, Torp-Pedersen C, Gislason GH (2018) Long-term use of proton pump inhibitors, dose\u2013response relationship and associated risk of ischemic stroke and myocardial infarction. J Intern Med 283(3):268\u2013281. https:\/\/doi.org\/10.1111\/joim.12698","journal-title":"J Intern Med"},{"issue":"6","key":"808_CR7","doi-asserted-by":"publisher","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","volume":"10","author":"AA Lambert","year":"2015","unstructured":"Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA (2015) Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One 10(6):e0128004. https:\/\/doi.org\/10.1371\/journal.pone.0128004","journal-title":"PLoS One"},{"issue":"35","key":"808_CR8","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.3748\/wjg.v23.i35.6500","volume":"23","author":"A Trifan","year":"2017","unstructured":"Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L (2017) Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol 23(35):6500. https:\/\/doi.org\/10.3748\/wjg.v23.i35.6500","journal-title":"World J Gastroenterol"},{"issue":"4","key":"808_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","volume":"26","author":"F Sierra","year":"2007","unstructured":"Sierra F, Suarez M, Rey M, Vela MF (2007) Systematic review: proton pump inhibitor-associated acute interstitial nephritis. Aliment Pharmacol Ther 26(4):545\u2013553. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03407.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"808_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176(2):238\u2013246. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7193","journal-title":"JAMA Intern Med"},{"issue":"1","key":"808_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","volume":"17","author":"P Arora","year":"2016","unstructured":"Arora P, Gupta A, Golzy M, Patel N, Carter RL, Jalal K, Lohr JW (2016) Proton pump inhibitors are associated with increased risk of development of chronic kidney disease. BMC Nephrol 17(1):112. https:\/\/doi.org\/10.1186\/s12882-016-0325-4","journal-title":"BMC Nephrol"},{"issue":"10","key":"808_CR12","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1681\/asn.2015121377","volume":"27","author":"Y Xie","year":"2016","unstructured":"Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z (2016) Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 27(10):3153\u20133163. https:\/\/doi.org\/10.1681\/asn.2015121377","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"808_CR13","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","volume":"91","author":"Y Xie","year":"2017","unstructured":"Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z (2017) Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int 91(6):1482\u20131494. https:\/\/doi.org\/10.1016\/j.kint.2016.12.021","journal-title":"Kidney Int"},{"issue":"3","key":"808_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, St\u00f6rk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S, Investigators COMPASS (2019) Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 157(3):682\u2013691.e2. https:\/\/doi.org\/10.1053\/j.gastro.2019.05.056","journal-title":"Gastroenterology"},{"issue":"4","key":"808_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1053\/j.gastro.2019.07.067","volume":"158","author":"J Simin","year":"2020","unstructured":"Simin J, Liu Q, Fornes R, Brusselaers N (2020) Safety of proton pump inhibitors questioned based on a large randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 158(4):1172\u20131173. https:\/\/doi.org\/10.1053\/j.gastro.2019.07.067","journal-title":"Gastroenterology"},{"issue":"2","key":"808_CR16","doi-asserted-by":"publisher","first-page":"e87952","DOI":"10.1371\/journal.pone.0087952","volume":"9","author":"C-C Liang","year":"2014","unstructured":"Liang C-C, Muo C-H, Wang IK, Chang CT, Chou CY, Liu JH, Yen TH, Huang CC, Chung CJ (2014) Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications. PLoS One 9(2):e87952. https:\/\/doi.org\/10.1371\/journal.pone.0087952","journal-title":"PLoS One"},{"issue":"8","key":"808_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2215\/CJN.09260913","volume":"9","author":"C-C Liang","year":"2014","unstructured":"Liang C-C, Wang S-M, Kuo H-L, Chang CT, Liu JH, Lin HH, Wang IK, Yang YF, Lu YJ, Chou CY, Huang CC (2014) Upper gastrointestinal bleeding in patients with CKD. Clin J Am Soc Nephrol 9(8):1354\u20131359. https:\/\/doi.org\/10.2215\/CJN.09260913","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"808_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40620-014-0132-6","volume":"28","author":"H Trivedi","year":"2015","unstructured":"Trivedi H, Yang J, Szabo A (2015) Gastrointestinal bleeding in patients on long-term dialysis. J Nephrol 28(2):235\u2013243. https:\/\/doi.org\/10.1007\/s40620-014-0132-6","journal-title":"J Nephrol"},{"issue":"3","key":"808_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1681\/asn.2011070658","volume":"23","author":"J-Y Yang","year":"2012","unstructured":"Yang J-Y, Lee T-C, Montez-Rath ME, Paik J, Chertow GM, Desai M, Winkelmayer WC (2012) Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol 23(3):495\u2013506. https:\/\/doi.org\/10.1681\/asn.2011070658","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"808_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.gie.2008.10.051","volume":"70","author":"S Loperfido","year":"2009","unstructured":"Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, Caroli A, Dal B\u00f2 N, Monica F, Fabris L, Heras Salvat H, Bassi N, Okolicsanyi L (2009) Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 70(2):212\u2013224. https:\/\/doi.org\/10.1016\/j.gie.2008.10.051","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"808_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2369-14-15","volume":"14","author":"C-C Kuo","year":"2013","unstructured":"Kuo C-C, Kuo H-W, Lee IM, Lee C-T, Yang C-Y (2013) The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study. BMC Nephrol 14(1):15. https:\/\/doi.org\/10.1186\/1471-2369-14-15","journal-title":"BMC Nephrol"},{"issue":"12","key":"808_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jcma.2018.03.007","volume":"81","author":"X-H Lin","year":"2018","unstructured":"Lin X-H, Lin C-C, Wang Y-J, Luo JC, Young SH, Chen PH, Hou MC, Lee FY (2018) Risk factors of the peptic ulcer bleeding in aging uremia patients under regular hemodialysis. J Chin Med Assoc 81(12):1027\u20131032. https:\/\/doi.org\/10.1016\/j.jcma.2018.03.007","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"808_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1515\/jtim-2017-0019","volume":"5","author":"SM Laeeq","year":"2017","unstructured":"Laeeq SM, Tasneem AA, Hanif FM, Luck NH, Mandhwani R, Wadhva R (2017) Upper gastrointestinal bleeding in patients with end stage renal disease: causes, characteristics and factors associated with need for endoscopic therapeutic intervention. J Transl Int Med 5(2):106\u2013111. https:\/\/doi.org\/10.1515\/jtim-2017-0019","journal-title":"J Transl Int Med"},{"issue":"11","key":"808_CR24","first-page":"2329","volume":"91","author":"N Chalasani","year":"1996","unstructured":"Chalasani N, Cotsonis G, Wilcox CM (1996) Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol 91(11):2329\u20132332","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"808_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.7326\/0003-4819-102-5-588","volume":"102","author":"GR Zuckerman","year":"1985","unstructured":"Zuckerman GR, Cornette GL, Clouse RE, Harter HR (1985) Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 102(5):588\u2013592. https:\/\/doi.org\/10.7326\/0003-4819-102-5-588","journal-title":"Ann Intern Med"},{"issue":"4","key":"808_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1046\/j.1523-1755.2003.00225.x","volume":"64","author":"H Wasse","year":"2003","unstructured":"Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO (2003) Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int 64(4):1455\u20131461. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00225.x","journal-title":"Kidney Int"},{"issue":"5","key":"808_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF02773912","volume":"15","author":"N Tani","year":"1980","unstructured":"Tani N, Harasawa S, Suzuki S, Miwa M, Sakita R, Nomiyama T, Watanabe H, Senoue I, Kikuchi K, Miwa T (1980) Lesions of the upper gastrointestinal tract in patients with chronic renal failure. Gastroenterol Jpn 15(5):480\u2013484. https:\/\/doi.org\/10.1007\/BF02773912","journal-title":"Gastroenterol Jpn"},{"issue":"36","key":"808_CR28","doi-asserted-by":"publisher","first-page":"e1482","DOI":"10.1097\/MD.0000000000001482","volume":"94","author":"Y-C Lee","year":"2015","unstructured":"Lee Y-C, Hung S-Y, Wang H-H, Wang H-K, Lin C-W, Chang M-Y, Ho L-C, Chen Y-T, Wu C-F, Chen H-C, Wang W-M, Sung J-M, Chiou Y-Y, Lin S-H (2015) Different risk of common gastrointestinal disease between groups undergoing hemodialysis or peritoneal dialysis or with non-end stage renal disease: a nationwide population-based cohort study. Medicine (Baltimore) 94(36):e1482. https:\/\/doi.org\/10.1097\/MD.0000000000001482","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"808_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/oxfordjournals.ndt.a092460","volume":"8","author":"U Gladziwa","year":"1993","unstructured":"Gladziwa U, Hasse G, Handt S, Riehl J, Wietholtz H, Dakshinamurty KV, Gl\u00f6ckner WM, Sieberth HG (1993) Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transplant 8(4):301\u2013306. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a092460","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"808_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/BF02367783","volume":"30","author":"D Jaspersen","year":"1995","unstructured":"Jaspersen D, Fassbinder W, Heinkele P, Kronsbein H, Schorr W, Raschka C, Brennenstuhl M (1995) Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol 30(5):585\u2013588. https:\/\/doi.org\/10.1007\/BF02367783","journal-title":"J Gastroenterol"},{"key":"808_CR31","doi-asserted-by":"publisher","first-page":"785892","DOI":"10.1155\/2013\/785892","volume":"2013","author":"M Gu","year":"2013","unstructured":"Gu M, Xiao S, Pan X, Zhang G (2013) Helicobacter pylori infection in dialysis patients: a meta-analysis. Gastroenterol Res Pract 2013:785892. https:\/\/doi.org\/10.1155\/2013\/785892","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"808_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000336107","volume":"35","author":"P Sood","year":"2012","unstructured":"Sood P, Kumar G, Nanchal R, Sakhuja A, Ahmad S, Ali M, Kumar N, Ross EA (2012) Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding. Am J Nephrol 35(3):216\u2013224. https:\/\/doi.org\/10.1159\/000336107","journal-title":"Am J Nephrol"},{"issue":"1","key":"808_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2369-14-97","volume":"14","author":"J-Y Yang","year":"2013","unstructured":"Yang J-Y, Lee T-C, Montez-Rath ME, Chertow GM, Winkelmayer WC (2013) Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol 14(1):97. https:\/\/doi.org\/10.1186\/1471-2369-14-97","journal-title":"BMC Nephrol"},{"issue":"2","key":"808_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1542-4758.2006.00092.x","volume":"10","author":"GR Bailie","year":"2006","unstructured":"Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saito A, Bragg-Gresham JL, Gillespie BW, Young EW (2006) Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int 10(2):180\u2013188. https:\/\/doi.org\/10.1111\/j.1542-4758.2006.00092.x","journal-title":"Hemodial Int"},{"issue":"12","key":"808_CR35","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/jbmr.3842","volume":"34","author":"M Fusaro","year":"2019","unstructured":"Fusaro M, D\u2019Arrigo G, Pitino A, Iervasi G, Tentori F, Robinson B, Aghi A, Bieber B, Mccullogh K, Fabris F, Plebani M, Giannini S, Gallieni M, Tripepi G (2019) Increased risk of bone fractures in hemodialysis patients treated with proton pump inhibitors in real world: results from the dialysis outcomes and practice patterns study (DOPPS). J Bone Miner Res 34(12):2238\u20132245. https:\/\/doi.org\/10.1002\/jbmr.3842","journal-title":"J Bone Miner Res"},{"key":"808_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2019.11.002","volume":"72","author":"I Kosedo","year":"2020","unstructured":"Kosedo I, Tokushige A, Takumi T, Yoshikawa A, Teraguchi K, Takenouchi K, Shiraishi K, Ikeda D, Imamura M, Sonoda T, Kanda D, Ikeda Y, Ido A, Ohishi M (2020) Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: Insight from the kids registry. Eur J Intern Med 72:79\u201387. https:\/\/doi.org\/10.1016\/j.ejim.2019.11.002","journal-title":"Eur J Intern Med"},{"issue":"10","key":"808_CR37","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.2215\/cjn.02190218","volume":"13","author":"C Vangala","year":"2018","unstructured":"Vangala C, Niu J, Lenihan CR, Mitch WE, Navaneethan SD, Winkelmayer WC (2018) Proton pump inhibitors, histamine-2 receptor antagonists, and hip fracture risk among patients on hemodialysis. Clin J Am Soc Nephrol 13(10):1534\u20131541. https:\/\/doi.org\/10.2215\/cjn.02190218","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"808_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ekir.2017.11.001","volume":"3","author":"ALM de Francisco","year":"2018","unstructured":"de Francisco ALM, Varas J, Ramos R, Merello JI, Canaud B, Stuard S, Pascual J, Aljama P, Optimizing Results in Dialysis (ORD) Group (2018) Proton pump inhibitor usage and the risk of mortality in hemodialysis patients. Kidney Int Rep 3(2):374\u2013384. https:\/\/doi.org\/10.1016\/j.ekir.2017.11.001","journal-title":"Kidney Int Rep"},{"issue":"8","key":"808_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40264-013-0062-6","volume":"36","author":"M Fusaro","year":"2013","unstructured":"Fusaro M, Noale M, Tripepi G, Giannini S, D'Angelo A, Pica A, Cal\u00f2 LA, Miozzo D, Gallieni M (2013) Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis. Drug Saf 36(8):635\u2013642. https:\/\/doi.org\/10.1007\/s40264-013-0062-6","journal-title":"Drug Saf"},{"issue":"11","key":"808_CR40","doi-asserted-by":"publisher","first-page":"e0224859","DOI":"10.1371\/journal.pone.0224859","volume":"14","author":"S Maeda","year":"2019","unstructured":"Maeda S, Yamaguchi M, Maeda K, Kobayashi N, Izumi N, Nagai M, Obayashi T, Ohashi W, Katsuno T, Nobata H, Ito Y (2019) Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients. PLoS One 14(11):e0224859. https:\/\/doi.org\/10.1371\/journal.pone.0224859","journal-title":"PLoS One"},{"issue":"2","key":"808_CR41","doi-asserted-by":"publisher","first-page":"e0148806","DOI":"10.1371\/journal.pone.0148806","volume":"11","author":"M P\u00e9rez-Fontan","year":"2016","unstructured":"P\u00e9rez-Fontan M, Machado Lopes D, Garc\u00eda Enr\u00edquez A, L\u00f3pez-Calvi\u00f1o B, L\u00f3pez-Mu\u00f1iz A, Garc\u00eda Falc\u00f3n T, Rodr\u00edguez-Carmona A (2016) Inhibition of gastric acid secretion by H2 receptor antagonists associates a definite risk of enteric peritonitis and infectious mortality in patients treated with peritoneal dialysis. PLoS One 11(2):e0148806. https:\/\/doi.org\/10.1371\/journal.pone.0148806","journal-title":"PLoS One"},{"issue":"16","key":"808_CR42","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.3748\/wjg.v21.i16.4919","volume":"21","author":"YR Song","year":"2015","unstructured":"Song YR, Kim HJ, Kim J-K, Kim SG, Kim SE (2015) Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis. World J Gastroenterol 21(16):4919\u20134924. https:\/\/doi.org\/10.3748\/wjg.v21.i16.4919","journal-title":"World J Gastroenterol"},{"issue":"3","key":"808_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/0886022X.2011.560407","volume":"33","author":"C-C Liang","year":"2011","unstructured":"Liang C-C, Wang IK, Lin H-H, Yeh H-C, Liu J-H, Kuo H-L, Hsu W-M, Huang C-C, Chang C-T (2011) Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients. Ren Fail 33(3):323\u2013328. https:\/\/doi.org\/10.3109\/0886022X.2011.560407","journal-title":"Ren Fail"},{"issue":"8","key":"808_CR44","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/ndt\/17.8.1434","volume":"17","author":"H Strid","year":"2002","unstructured":"Strid H, Simr\u00e9n M, Johansson A, Svedlund J, Samuelsson O, Bj\u00f6rnsson ES (2002) The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant 17(8):1434\u20131439. https:\/\/doi.org\/10.1093\/ndt\/17.8.1434","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"808_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10157-015-1130-2","volume":"20","author":"T Namikoshi","year":"2016","unstructured":"Namikoshi T, Harada K, Hatta H, Tokura T, Oshiro Y, Nishizaki T, Obata T, Mori M, Fueki T, Fujimoto S, Haruna Y, Kuwabara A, Yorimitsu D, Ihoriya C, Kadoya H, Itano S, Fujimoto Y, Komai N, Sasaki T, Kashihara N (2016) Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis. Clin Exp Nephrol 20(1):134\u2013142. https:\/\/doi.org\/10.1007\/s10157-015-1130-2","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"808_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jcpt.12769","volume":"44","author":"H-J Zhong","year":"2019","unstructured":"Zhong H-J, Lin D, Lu Z-Y, Yang W-Y, Chen Y (2019) Use of gastric-acid suppressants may be a risk factor for enteric peritonitis in patients undergoing peritoneal dialysis: a meta-analysis. J Clin Pharm Ther 44(2):209\u2013215. https:\/\/doi.org\/10.1111\/jcpt.12769","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"808_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/MEG.0000000000001578","volume":"32","author":"A Abdel-Razik","year":"2019","unstructured":"Abdel-Razik A, Abdelsalam M, Gad DF, Abdelwahab A, Tawfik M, Elzehery R, Elhelaly R, Hasan AS, El-Wakeel N, Eldars W (2019) Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors. Eur J Gastroenterol Hepatol 32(6):718\u2013726. https:\/\/doi.org\/10.1097\/MEG.0000000000001578","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"808_CR48","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.nephro.2017.06.005","volume":"14","author":"G Desbuissons","year":"2018","unstructured":"Desbuissons G, Deray G, Mercadal L (2018) Inhibiteurs de la pompe \u00e0 protons et rein. Nephrol Ther 14:S115\u2013S124. https:\/\/doi.org\/10.1016\/j.nephro.2017.06.005","journal-title":"Nephrol Ther"},{"issue":"11","key":"808_CR49","doi-asserted-by":"publisher","first-page":"e112558","DOI":"10.1371\/journal.pone.0112558","volume":"9","author":"CH Park","year":"2014","unstructured":"Park CH, Kim EH, Roh YH, Kim HY, Lee SK (2014) The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One 9(11):e112558. https:\/\/doi.org\/10.1371\/journal.pone.0112558","journal-title":"PLoS One"},{"issue":"4","key":"808_CR50","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/hdi.12437","volume":"20","author":"R Ago","year":"2016","unstructured":"Ago R, Shindo T, Banshodani M, Shintaku S, Moriishi M, Masaki T, Kawanishi H (2016) Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: a cross-sectional, 1-year, retrospective cohort study. Hemodial Int 20(4):580\u2013588. https:\/\/doi.org\/10.1111\/hdi.12437","journal-title":"Hemodial Int"},{"issue":"3","key":"808_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000360011","volume":"39","author":"M Alhosaini","year":"2014","unstructured":"Alhosaini M, Walter JS, Singh S, Dieter RS, Hsieh A, Leehey DJ (2014) Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors. Am J Nephrol 39(3):204\u2013209. https:\/\/doi.org\/10.1159\/000360011","journal-title":"Am J Nephrol"},{"issue":"1","key":"808_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12882-015-0139-9","volume":"16","author":"PS Misra","year":"2015","unstructured":"Misra PS, Alam A, Lipman ML, Nessim SJ (2015) The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study. BMC Nephrol 16(1):136. https:\/\/doi.org\/10.1186\/s12882-015-0139-9","journal-title":"BMC Nephrol"},{"key":"808_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejim.2016.01.026","volume":"30","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Milic S, Stimac D, Zaputovic L, Lukenda Zanko V, Gulin T, Jakopcic I, Klaric D, Gulin M, Orlic L (2016) Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? Eur J Intern Med 30:99\u2013103. https:\/\/doi.org\/10.1016\/j.ejim.2016.01.026","journal-title":"Eur J Intern Med"},{"issue":"11","key":"808_CR54","doi-asserted-by":"publisher","first-page":"e0143656","DOI":"10.1371\/journal.pone.0143656","volume":"10","author":"A Nakashima","year":"2015","unstructured":"Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T (2015) Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study. PLoS One 10(11):e0143656. https:\/\/doi.org\/10.1371\/journal.pone.0143656","journal-title":"PLoS One"},{"issue":"3","key":"808_CR55","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1681\/ASN.2017080849","volume":"29","author":"Y Sakaguchi","year":"2018","unstructured":"Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I (2018) Magnesium and risk of hip fracture among patients undergoing hemodialysis. J Am Soc Nephrol 29(3):991\u2013999. https:\/\/doi.org\/10.1681\/ASN.2017080849","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"808_CR56","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jnutbio.2012.12.008","volume":"24","author":"MM Belluci","year":"2013","unstructured":"Belluci MM, Schoenmaker T, Rossa-Junior C, Orrico SR, de Vries TJ, Everts V (2013) Magnesium deficiency results in an increased formation of osteoclasts. J Nutr Biochem 24(8):1488\u20131498. https:\/\/doi.org\/10.1016\/j.jnutbio.2012.12.008","journal-title":"J Nutr Biochem"},{"issue":"6","key":"808_CR57","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/asn.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Dr\u00fceke TB, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators (2015) Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26(6):1466\u20131475. https:\/\/doi.org\/10.1681\/asn.2014040414","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"808_CR58","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1111\/febs.12478","volume":"280","author":"J Costa-Rodrigues","year":"2013","unstructured":"Costa-Rodrigues J, Reis S, Teixeira S, Lopes S, Fernandes MH (2013) Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J 280(20):5052\u20135064. https:\/\/doi.org\/10.1111\/febs.12478","journal-title":"FEBS J"},{"issue":"7","key":"808_CR59","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O\u2019Connell","year":"2005","unstructured":"O\u2019Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118(7):778\u2013781. https:\/\/doi.org\/10.1016\/j.amjmed.2005.02.007","journal-title":"Am J Med"},{"issue":"2","key":"808_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1742-1241.2008.01883.x","volume":"63","author":"A Kirkpantur","year":"2009","unstructured":"Kirkpantur A, Altun B, Arici M, Turgan C (2009) Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients. Int J Clin Pract 63(2):261\u2013268. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01883.x","journal-title":"Int J Clin Pract"},{"issue":"4","key":"808_CR61","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1536\/ihj.18-584","volume":"60","author":"S Li","year":"2019","unstructured":"Li S, Liu F, Chen C, Zhu W, Ma J, Hu J, Xu J, Hong K (2019) Real-World relationship between proton pump inhibitors and cerebro-cardiovascular outcomes independent of clopidogrel. Int Heart J 60(4):910\u2013918. https:\/\/doi.org\/10.1536\/ihj.18-584","journal-title":"Int Heart J"},{"issue":"7","key":"808_CR62","doi-asserted-by":"publisher","first-page":"e0199160","DOI":"10.1371\/journal.pone.0199160","volume":"13","author":"T Okamoto","year":"2018","unstructured":"Okamoto T, Hatakeyama S, Hosogoe S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C (2018) Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis. PLoS One 13(7):e0199160. https:\/\/doi.org\/10.1371\/journal.pone.0199160","journal-title":"PLoS One"},{"issue":"11","key":"808_CR63","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1093\/ndt\/gfs126","volume":"27","author":"S Van Laecke","year":"2012","unstructured":"Van Laecke S, Van Biesen W, Vanholder R (2012) Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant 27(11):4003\u20134010. https:\/\/doi.org\/10.1093\/ndt\/gfs126","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"808_CR64","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40620-019-00601-6","volume":"32","author":"J Xiong","year":"2019","unstructured":"Xiong J, He T, Wang M, Zhang Y, Wang Y, Huang Y, Feng B, Zhang J, Zhao J (2019) Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol 32(5):791\u2013802. https:\/\/doi.org\/10.1007\/s40620-019-00601-6","journal-title":"J Nephrol"},{"issue":"2","key":"808_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000498957","volume":"44","author":"L Wu","year":"2019","unstructured":"Wu L, Cai K, Luo Q, Wang L, Hong Y (2019) Baseline serum magnesium level and its variability in maintenance hemodialysis patients: associations with mortality. Kidney Blood Press Res 44(2):222\u2013232. https:\/\/doi.org\/10.1159\/000498957","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"808_CR66","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1440-1797.2012.01604.x","volume":"17","author":"MJ Cervelli","year":"2012","unstructured":"Cervelli MJ, Shaman A, Meade A, Carroll R, McDonald SP (2012) Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients. Nephrology (Carlton) 17(5):458\u2013465. https:\/\/doi.org\/10.1111\/j.1440-1797.2012.01604.x","journal-title":"Nephrology (Carlton)"},{"issue":"12","key":"808_CR67","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","volume":"118","author":"G Yepuri","year":"2016","unstructured":"Yepuri G, Sukhovershin R, Nazari-Shafti TZ, Petrascheck M, Ghebre YT, Cooke JP (2016) Proton pump inhibitors accelerate endothelial senescence. Circ Res 118(12):e36\u2013e42. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308807","journal-title":"Circ Res"},{"issue":"12","key":"808_CR68","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00535-013-0774-5","volume":"48","author":"W Liu","year":"2013","unstructured":"Liu W, Baker SS, Trinidad J, Burlingame AL, Baker RD, Forte JG, Virtuoso LP, Egilmez NK, Zhu L (2013) Inhibition of lysosomal enzyme activities by proton pump inhibitors. J Gastroenterol 48(12):1343\u20131352. https:\/\/doi.org\/10.1007\/s00535-013-0774-5","journal-title":"J Gastroenterol"},{"issue":"8","key":"808_CR69","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","volume":"128","author":"YT Ghebremariam","year":"2013","unstructured":"Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP (2013) Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation 128(8):845\u2013853. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003602","journal-title":"Circulation"},{"key":"808_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.niox.2018.06.004","volume":"78","author":"X Liu","year":"2018","unstructured":"Liu X, Xu X, Shang R, Chen Y (2018) Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease. Nitric Oxide 78:113\u2013120. https:\/\/doi.org\/10.1016\/j.niox.2018.06.004","journal-title":"Nitric Oxide"},{"issue":"6","key":"808_CR71","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/cpt.1762","volume":"107","author":"I-J Tsai","year":"2020","unstructured":"Tsai I-J, Lai T-S, Shiao C-C, Huang T-M, Wang C-H, Tsao C-H, Chen L-W, Lin Y-H, Chen L, Wu V-C, Chu T-S, National Taiwan University Hospital Study Group on Acute Renal Failure (NSARF) (2020) Proton-pump inhibitors augment the risk of major adverse cardiovascular events and end-stage renal disease in patients with acute kidney injury after temporary dialysis. Clin Pharmacol Ther 107(6):1434\u20131445. https:\/\/doi.org\/10.1002\/cpt.1762","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"808_CR72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ki.2013.327","volume":"85","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y (2014) Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85(1):174\u2013181. https:\/\/doi.org\/10.1038\/ki.2013.327","journal-title":"Kidney Int"},{"issue":"6","key":"808_CR73","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000503805","volume":"50","author":"T Li","year":"2019","unstructured":"Li T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, Dragoi S (2019) Rationale and strategies for preserving residual kidney function in dialysis patients. Am J Nephrol 50(6):411\u2013421. https:\/\/doi.org\/10.1159\/000503805","journal-title":"Am J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00808-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:54Z","timestamp":1777564494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/3\/661\/8325757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00808-y","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There was no research involving human or animal participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"No consent was needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}